Investor Relations

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases
November 11, 2021
electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
ROCKAWAY, NJ , Nov. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be available for virtual one-on-one meetings at the Canaccord Genuity MedTech & Diagnostics Forum .
November 4, 2021
electroCore Announces Third Quarter 2021 Financial Results
Third quarter 2021 revenue grew 17% sequentially and 38% over third quarter 2020 Company to host a conference call and webcast today, November 4, 2021 at 4:30 pm ET ROCKAWAY, N.J. , Nov. 04, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine

Investor Contact

Investor Relations

CG Capital
Rich Cockrell
404.736.3838
ECOR@cg.capital